Human-Animal Bond Reaches New High as the Science on the Health Benefits of Pets Goes Mainstream

HABRI’s 2026 survey found 74% of Americans own at least one pet and another 15% intend to get one; 98% of pet owners reported at least one health benefit. Awareness of researched benefits rose to an average of 18 per person from 12 in 2021, while 83% support pet-friendly public spaces and 80% favor fewer pet restrictions in rental housing. Pet ownership costs and housing restrictions remain barriers, cited by 37% and 29% of potential owners, respectively.

Analysis

The investable signal is not the reported health awareness; it is whether that awareness converts into recurring spend per pet. If it does, veterinary services, diagnostics, premium food and pet insurance could gain more durable demand than discretionary accessories. Idexx Laboratories, Zoetis, Chewy, Petco and Trupanion are relevant exposure points, but the survey does not establish incremental revenue, category mix or who captures the spend. Clinics and insurers may benefit from stronger preventive-care intent; retailers face a less favorable split if households prioritize veterinary bills and nutrition over discretionary goods.

The key counterweight is affordability: reported cost concerns and housing restrictions make stated intent a weak proxy for completed adoptions. More pets could also raise total household costs enough to delay care or drive substitution toward lower-priced food and online channels. HABRI is a nonprofit advocating for the human-animal bond; its online survey measures reported attitudes, not transactions, and should not be treated as an independent spending forecast.

Near term, this is a sentiment signal, not a standalone catalyst. Over 1–3 months, check earnings commentary for comparable sales, customer growth, vet visit volumes, insurance policy additions and price/mix. Over 6–18 months, adoption conversion and pet-friendly rental policies matter more than awareness. Contrarian read: broad awareness may already be mature; affordability and capacity, not demand for pets, are the binding constraints. No high-conviction trade until spending data confirms conversion.

Key Decisions for Investors

• No immediate sector position on this survey alone. Treat it as a watch item for recurring-spend exposure rather than evidence of near-term sales acceleration.
• Monitor Idexx Laboratories and Zoetis for diagnostic and preventive-care growth, and Chewy and Petco for customer trends and category mix. Upgrade the thesis only if company disclosures show sustained volume or customer growth—not just higher prices.
• Track Trupanion and broader pet-insurance uptake as a possible second-order beneficiary of rising care costs; verify policy growth, retention and claims trends before taking exposure.
• Falsify the bullish conversion thesis if adoption intent fails to translate into reported pet ownership or if earnings show weaker transaction volumes, trading down, or deferred veterinary care. Housing-policy changes and adoption data are useful 6–18 month checks.